TURKEL CATHERINE C. 4
4 · Lexaria Bioscience Corp. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Director
Transactions
- Purchase
Common Shares
2023-02-09$2.84/sh+1,500$4,267→ 1,500 total
Holdings
- 3,400
Stock Options
Exercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying) - 5,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (1,600 underlying)